J
Judith K. Wolf
Researcher at University of Texas MD Anderson Cancer Center
Publications - 101
Citations - 5399
Judith K. Wolf is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Ovarian cancer & Cancer. The author has an hindex of 40, co-authored 101 publications receiving 5062 citations. Previous affiliations of Judith K. Wolf include Baylor College of Medicine & University of Texas at Austin.
Papers
More filters
Journal ArticleDOI
Depression, anxiety, and quality of life in patients with epithelial ovarian cancer.
Diane Bodurka-Bevers,Karen Basen-Engquist,Cindy L. Carmack,Mary A. Fitzgerald,Judith K. Wolf,Carl de Moor,David M. Gershenson +6 more
TL;DR: Clinically significant depression and anxiety may be more prevalent in patients with EOC than previously reported and future studies of screening for and treating psychological distress are being designed to improve QOL in these women.
Journal ArticleDOI
Rankings and symptom assessments of side effects from chemotherapy: insights from experienced patients with ovarian cancer
Charlotte C. Sun,Diane C. Bodurka,Candice B. Weaver,Rafia S. Rasu,Judith K. Wolf,Michael W. Bevers,Judith A. Smith,J. Taylor Wharton,Edward B. Rubenstein +8 more
TL;DR: While MSAS scores and VAS rankings showed consistency across some health states, this was not true for CINV, suggesting that current symptom status may only influence patient preferences for selected side effects.
Journal Article
Enhanced c-erbB-2/neu Expression in Human Ovarian Cancer Cells Correlates With More Severe Malignancy That Can Be Suppressed by E1A
TL;DR: E1A is a tumor suppressor gene for c-erbB-2/neu-overexpressing human ovarian cancer cells and may be useful in developing therapeutic reagents for these human cancers.
Journal ArticleDOI
A phase 2 study of the oral mammalian target of rapamycin inhibitor, everolimus, in patients with recurrent endometrial carcinoma
Brian M. Slomovitz,Brian M. Slomovitz,Karen H. Lu,T. Johnston,Robert L. Coleman,Mark F. Munsell,Russell Broaddus,Cheryl L. Walker,Lois M. Ramondetta,Thomas W. Burke,David M. Gershenson,Judith K. Wolf +11 more
TL;DR: Dysregulation of phosphatase and tensin homolog (PTEN) and the gene that encodes the p110α catalytic subunit ofosphatidylinositol‐3‐kinase (PI3K), PIK3CA, are the most common mutations in endometrial carcinoma.
Journal ArticleDOI
Ovarian and extraovarian endometriosis-associated cancer.
Susan C. Modesitt,Guillermo Tortolero-Luna,Jubilee B. Robinson,David M. Gershenson,Judith K. Wolf +4 more
TL;DR: Women with endometriosis‐associated cancers are typically premenopausal, have a high incidence of endometioid and clear cell histologies, and have early stage disease.